Tabuk Pharmaceutical develops, manufactures, markets, and distributes branded generic pharmaceuticals and under-licensed products globally. Established in 1994 in Saudi Arabia, Tabuk Pharmaceuticals’ fast growth has allowed it to become a global company, with a strong focus on the Middle East and North Africa region. Today, the company is present in over 20 markets and employs over 1,500 employees. Tabuk Pharmaceuticals operates in multiple therapeutic areas including CNS, cardiovascular, anti-infectives, respiratory, and muscular skeletal system

Tabuk Pharmaceuticals’ distinctive marketing capabilities, state-of-the-art manufacturing facilities, broad product portfolio, deep understanding of pharmaceutical regulations, and strong partnerships and affiliations, helped create a leading pharmaceutical player in the MENA region

Tabuk Pharmaceuticals’ aim is to consistently exceed the demands of our patients by providing them with the best quality drugs at affordable prices. It is a fully owned subsidiary of Astra Industrial Group, a publicly traded company on the Saudi stock exchange

For more information, click here